125 related articles for article (PubMed ID: 10828795)
1. Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas.
Delorge S; Saussez S; Pelc P; Devroede B; Marchant H; Burchert M; Zeng FY; Danguy A; Salmon I; Gabius HJ; Kiss R; Hassid S
Otolaryngol Head Neck Surg; 2000 Jun; 122(6):834-41. PubMed ID: 10828795
[TBL] [Abstract][Full Text] [Related]
2. The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers.
Choufani G; Nagy N; Saussez S; Marchant H; Bisschop P; Burchert M; Danguy A; Louryan S; Salmon I; Gabius HJ; Kiss R; Hassid S
Cancer; 1999 Dec; 86(11):2353-63. PubMed ID: 10590378
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
Plzák J; Betka J; Smetana K; Chovanec M; Kaltner H; André S; Kodet R; Gabius HJ
Eur J Cancer; 2004 Oct; 40(15):2324-30. PubMed ID: 15454259
[TBL] [Abstract][Full Text] [Related]
4. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
5. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
[TBL] [Abstract][Full Text] [Related]
6. Endogenous lectins (galectins-1 and -3) as probes to detect differentiation-dependent alterations in human squamous cell carcinomas of the oropharynx and larynx.
Plzak J; Smetana K; Betka J; Kodet R; Kaltner H; Gabius HJ
Int J Mol Med; 2000 Apr; 5(4):369-72. PubMed ID: 10719052
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.
Betka J; Plzák J; Smetana K; Gabius HJ
Acta Otolaryngol; 2003 Jan; 123(2):261-3. PubMed ID: 12701754
[TBL] [Abstract][Full Text] [Related]
8. Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas.
François C; van Velthoven R; De Lathouwer O; Moreno C; Peltier A; Kaltner H; Salmon I; Gabius HJ; Danguy A; Decaestecker C; Kiss R
Am J Clin Pathol; 1999 Aug; 112(2):194-203. PubMed ID: 10439799
[TBL] [Abstract][Full Text] [Related]
9. Expression of galectins in head and neck squamous cell carcinoma.
Gillenwater A; Xu XC; el-Naggar AK; Clayman GL; Lotan R
Head Neck; 1996; 18(5):422-32. PubMed ID: 8864733
[TBL] [Abstract][Full Text] [Related]
10. Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas?
Cada Z; Chovanec M; Smetana K; Betka J; Lacina L; Plzák J; Kodet R; Stork J; Lensch M; Kaltner H; André S; Gabius HJ
Histol Histopathol; 2009 Jan; 24(1):41-8. PubMed ID: 19012243
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 upregulation during tumor progression in head and neck cancer.
Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ligands for galectins, natural galactoside-binding immunoglobulin G subfractions and sarcolectin and also of the expression of calcyclin in thyroid lesions.
Nagy N; Decaestecker C; Dong X; Kaltner H; Schüring MP; Rocmans P; Danguy A; Gabius HJ; Kiss R; Salmon I
Histol Histopathol; 2000 Apr; 15(2):503-13. PubMed ID: 10809372
[TBL] [Abstract][Full Text] [Related]
13. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
Saussez S; Camby I; Toubeau G; Kiss R
Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
[TBL] [Abstract][Full Text] [Related]
14. Correlation of expression of nuclear proteins pKi67 and p63 with lectin histochemical features in head and neck squamous cell cancer.
Chovanec M; Smetana K; Betka J; Plzák J; Brabec J; Moya-Alvarez V; André S; Kodet R; Gabius HJ
Int J Oncol; 2005 Aug; 27(2):409-15. PubMed ID: 16010422
[TBL] [Abstract][Full Text] [Related]
15. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
[TBL] [Abstract][Full Text] [Related]
16. Differentiation-dependent glycosylation of cells in squamous cell epithelia detected by a mammalian lectin.
Plzák J; Holíková Z; Smetana K; Dvoránková B; Hercogová J; Kaltner H; Motlík J; Gabius HJ
Cells Tissues Organs; 2002; 171(2-3):135-44. PubMed ID: 12097836
[TBL] [Abstract][Full Text] [Related]
17. Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties.
André S; Ortega PJ; Perez MA; Roy R; Gabius HJ
Glycobiology; 1999 Nov; 9(11):1253-61. PubMed ID: 10536041
[TBL] [Abstract][Full Text] [Related]
18. Binding of T-antigen-bearing neoglycoprotein and peanut agglutinin to cultured tumor cells and breast carcinomas.
Gabius HJ; Schröter C; Gabius S; Brinck U; Tietze LF
J Histochem Cytochem; 1990 Nov; 38(11):1625-31. PubMed ID: 2212620
[TBL] [Abstract][Full Text] [Related]
19. Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: is there any prognostic relevance?
Fritz P; Seizer-Schmidt R; Mürdter TE; Kroemer HK; Aulitzky W; André S; Gabius HJ; Friedel G; Toomes H; Siegle I
Acta Histochem; 1999 Jul; 101(3):239-53. PubMed ID: 10443287
[TBL] [Abstract][Full Text] [Related]
20. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas.
Saussez S; Decaestecker C; Lorfevre F; Cucu DR; Mortuaire G; Chevalier D; Wacreniez A; Kaltner H; André S; Toubeau G; Camby I; Gabius HJ; Kiss R
Int J Oncol; 2007 May; 30(5):1109-17. PubMed ID: 17390012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
